menu search

1 under-the-radar stock that could triple by 2030

Viking Therapeutics is looking to profit from the expanding market for obesity drugs. The company's two leading candidates are currently in ...

November 4, 2023, 7:30 am

Buy hershey amid financial and technical strength

The Hershey Company reported strong Q3 2023 financial results, with a substantial increase in net sales driven by organic sales growth and strategic p...

November 4, 2023, 6:23 am

Is rivian stock a buy?

Rivian has the money it needs to get to the critical phase for its business success. Rivian also has so...

November 4, 2023, 5:21 am

Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance

In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer vac...

November 3, 2023, 8:30 pm

Aligos therapeutics to host kol event to discuss alg-000184 phase 1, aasld late breaker data

November 16 Event to feature KOL perspective on Emerging HBV Therapies SOUTH SAN FRANCISCO, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) — Aligos Therapeu...

November 3, 2023, 8:30 pm

Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance

In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer vac...

November 3, 2023, 8:30 pm

Sensei biotherapeutics reports favorable clinical data for sns-101 at 2023 sitc annual meeting

– Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potentially best-in-class pharmacokinetics, and encourag...

November 3, 2023, 8:05 pm

Kineta reports third quarter 2023 financial results and provides corporate update

Announced positive KVA12123 monotherapy safety data from its ongoing phase 1/2 VISTA-101 clinical trial...

November 3, 2023, 8:01 pm

New preliminary clinical data on potential of opus aav-based gene therapy for rare inherited retinal disease to be presented at the american academy of ophthalmology annual conference 2023

Data to be presented as part of gene augmentation therapy presentation RALEIGH, N.C., Nov. 03, 2023 (GLOBE NEWSWIRE) — Opus Genetics, a patient-focu...

November 3, 2023, 7:43 pm

Taysha gene therapies: tsha-102's potential is a 'buy'

Taysha Gene Therapies is a biotech stock focused on developing gene therapies for monogenic CNS diseases, with its lead candidate TSHA-102 targeting R...

November 3, 2023, 7:41 pm

Protara therapeutics announces third quarter 2023 financial results and business update

Dosing is progressing well in ADVANCED-1EXP trial evaluating TARA-002 in NMIBC patients with CIS; preliminary results expected in 1H24 Company initiat...

November 3, 2023, 12:00 pm

Morphic announces corporate highlights and financial results for the third quarter 2023

-Presented positive EMERALD-1 phase 2a data for MORF-057 in patients with moderate to severe ulcerative...

November 3, 2023, 11:00 am

Gilead to present late breaking data and real world evidence highlighting key hepatitis indications at the liver meeting® 2023

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of new viral hepatitis data at the America...

November 3, 2023, 11:00 am

Why is werewolf therapeutics (howl) stock up 20% today?

Werewolf Therapeutics (NASDAQ: HOWL ) stock is on the rise Friday after the company released preliminary data from the ...

November 3, 2023, 10:26 am

Turnstone biologics presents preclinical data highlighting potential for selected tumor-infiltrating lymphocyte (til) therapy in solid tumors at the 2023 society for immunotherapy of cancer (sitc) ann

Presentations showcase Turnstone’s novel Selected TIL programs which are designed to selectively expand the most potent tumor-reactive T cells for t...

November 3, 2023, 10:00 am

Gbp/usd forecast: pound sterling could extend rebound once 1.2200 is confirmed as support

GBP/USD gathered bullish momentum and climbed to a fresh 10-day high above 1.2220 on Thursday. The pair lost its traction early Friday and went into a...

November 3, 2023, 9:59 am

Eur/usd forecast: euro could test 1.0700 on a weak nfp print

EUR/USD went into a consolidation phase above 1.0600 early Friday. October Nonfarm Payrolls data could ...

November 3, 2023, 7:44 am

Pipeline moves: approval prospects rise for oesophageal cancer drug after trial completion

On a good note, we investigate the completion of a phase IIb trial in congestive heart failure and chro...

November 2, 2023, 8:29 pm

Dbv technologies to present new data at acaai 2023

Montrouge, France, November 2, 2023 DBV Technologies to Present New Data at ACAAI 2023 New data to include late-breaking abstract detailing interim 12...

November 2, 2023, 4:30 pm


Search within

Pages Search Results: